Business
Biotherapeutics company in Clayton to begin manufacturing potential COVID-19 treatment
Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton.
Details
Transcript
Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton.
Web Editor : Jason O. BoydPosted 2020-06-11T18:10:29-0400 - Updated 2020-06-11T18:10:29-0400
